From penicillin to vaccines to genome editing, all the greatest scientific discoveries have something in common: the determination to transform lives on a global scale, no matter what hurdles block the path of progress.
That’s why we named ourselves Volition, to honor the central importance and absolute focus of that purpose and determination in revolutionizing the way disease is diagnosed and monitored.
We believe wholeheartedly in the power of our technology, our products, and our people. Nucleosomics™ technology has the potential to play an important role in the fight to save lives and improve outcomes worldwide. This belief and passion are what drive and sustain us and everyone who joins us.
What we do and the way we do it is completely unique. We dare to challenge the status quo to advance the science of epigenetics and improve outcomes for people and animals worldwide. We seek to change the world by allowing physicians to use the hidden information in chromosomes to detect disease earlier, monitor it more effectively and help improve outcomes.
Our team are leading experts in epigenetics. For over a decade we have evolved and mastered our understanding of nucleosomes. We have developed and refined our technology to be what we believe to be the best-in-class in the diagnostics industry. Everything we do, we do to the very best of our ability.
We are inspired every day by the potential of what we do and what we can achieve together. Our horizon is continuously expanding beyond cancer to a whole range of life-altering diseases, beyond humans to animals, to find and address a host of unmet clinical needs, always with the patient at the forefront of our minds.
The science of what we do is detailed and complex, but Nu.Q® itself is not. A simple, routine blood test, like a blood sugar or cholesterol test, our goal is that Nu.Q® will be affordable and available to all. And this is the essence of who we are. We are in this together, for everyone.
